nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—CYP3A4—bone cancer	0.641	1	CbGaD
Codeine—UGT2B7—Epirubicin—bone cancer	0.206	0.877	CbGbCtD
Codeine—CYP2D6—Doxorubicin—bone cancer	0.0177	0.0753	CbGbCtD
Codeine—CYP3A4—Doxorubicin—bone cancer	0.0113	0.0479	CbGbCtD
Codeine—UGT2B4—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00281	0.0647	CbGpPWpGaD
Codeine—UGT2B7—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00256	0.0589	CbGpPWpGaD
Codeine—UGT2B4—Metapathway biotransformation—CYP4V2—bone cancer	0.00241	0.0554	CbGpPWpGaD
Codeine—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00174	0.0401	CbGpPWpGaD
Codeine—Rhinorrhoea—Cisplatin—bone cancer	0.00136	0.0184	CcSEcCtD
Codeine—UGT2B7—Estrogen metabolism—CYP3A4—bone cancer	0.00134	0.0308	CbGpPWpGaD
Codeine—Loss of libido—Methotrexate—bone cancer	0.00131	0.0177	CcSEcCtD
Codeine—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00126	0.029	CbGpPWpGaD
Codeine—Dihydrocodeine—CYP3A4—bone cancer	0.00123	0.181	CrCbGaD
Codeine—UGT2B7—Tamoxifen metabolism—CYP3A4—bone cancer	0.00118	0.0272	CbGpPWpGaD
Codeine—UGT2B7—Metapathway biotransformation—CYP4V2—bone cancer	0.0011	0.0252	CbGpPWpGaD
Codeine—Body temperature increased—Carboplatin—bone cancer	0.00106	0.0143	CcSEcCtD
Codeine—Ethylmorphine—CYP3A4—bone cancer	0.00103	0.151	CrCbGaD
Codeine—Hypothermia—Epirubicin—bone cancer	0.00101	0.0136	CcSEcCtD
Codeine—Body temperature decreased—Epirubicin—bone cancer	0.00101	0.0136	CcSEcCtD
Codeine—Lacrimation—Epirubicin—bone cancer	0.00096	0.013	CcSEcCtD
Codeine—Hydrocodone—CYP3A4—bone cancer	0.000945	0.138	CrCbGaD
Codeine—Hypothermia—Doxorubicin—bone cancer	0.000932	0.0126	CcSEcCtD
Codeine—Body temperature decreased—Doxorubicin—bone cancer	0.000932	0.0126	CcSEcCtD
Codeine—Polyuria—Cisplatin—bone cancer	0.000909	0.0123	CcSEcCtD
Codeine—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000898	0.0207	CbGpPWpGaD
Codeine—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000894	0.0206	CbGpPWpGaD
Codeine—Lacrimation—Doxorubicin—bone cancer	0.000889	0.012	CcSEcCtD
Codeine—Oxycodone—CYP3A4—bone cancer	0.000863	0.126	CrCbGaD
Codeine—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.00084	0.0193	CbGpPWpGaD
Codeine—Redness—Epirubicin—bone cancer	0.000837	0.0113	CcSEcCtD
Codeine—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000807	0.0186	CbGpPWpGaD
Codeine—Hydromorphone—CYP3A4—bone cancer	0.000783	0.115	CrCbGaD
Codeine—Redness—Doxorubicin—bone cancer	0.000774	0.0105	CcSEcCtD
Codeine—Irritability—Cisplatin—bone cancer	0.000762	0.0103	CcSEcCtD
Codeine—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000749	0.0172	CbGpPWpGaD
Codeine—Galantamine—CYP3A4—bone cancer	0.000747	0.109	CrCbGaD
Codeine—Dehydration—Cisplatin—bone cancer	0.000742	0.0101	CcSEcCtD
Codeine—Orthostatic hypotension—Cisplatin—bone cancer	0.000729	0.00987	CcSEcCtD
Codeine—Breast disorder—Cisplatin—bone cancer	0.000721	0.00977	CcSEcCtD
Codeine—Cramp muscle—Cisplatin—bone cancer	0.000719	0.00973	CcSEcCtD
Codeine—Nasopharyngitis—Cisplatin—bone cancer	0.000714	0.00967	CcSEcCtD
Codeine—UGT2B4—Phase II conjugation—GSTP1—bone cancer	0.000705	0.0162	CbGpPWpGaD
Codeine—Pancreatitis—Cisplatin—bone cancer	0.000676	0.00916	CcSEcCtD
Codeine—Sweating increased—Cisplatin—bone cancer	0.000672	0.0091	CcSEcCtD
Codeine—Bone disorder—Methotrexate—bone cancer	0.000668	0.00905	CcSEcCtD
Codeine—Morphine—CYP3A4—bone cancer	0.000666	0.0975	CrCbGaD
Codeine—Abdominal discomfort—Cisplatin—bone cancer	0.000661	0.00896	CcSEcCtD
Codeine—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000632	0.0146	CbGpPWpGaD
Codeine—OPRK1—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.00063	0.0145	CbGpPWpGaD
Codeine—Bone disorder—Epirubicin—bone cancer	0.000625	0.00847	CcSEcCtD
Codeine—Lacrimation increased—Epirubicin—bone cancer	0.000613	0.0083	CcSEcCtD
Codeine—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000607	0.014	CbGpPWpGaD
Codeine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000585	0.0135	CbGpPWpGaD
Codeine—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000584	0.0134	CbGpPWpGaD
Codeine—Bone disorder—Doxorubicin—bone cancer	0.000578	0.00783	CcSEcCtD
Codeine—Lacrimation increased—Doxorubicin—bone cancer	0.000567	0.00768	CcSEcCtD
Codeine—Bradycardia—Cisplatin—bone cancer	0.000562	0.00761	CcSEcCtD
Codeine—Dextromethorphan—CYP3A4—bone cancer	0.000559	0.0819	CrCbGaD
Codeine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00055	0.0127	CbGpPWpGaD
Codeine—Urinary tract disorder—Cisplatin—bone cancer	0.000545	0.00738	CcSEcCtD
Codeine—Urethral disorder—Cisplatin—bone cancer	0.000541	0.00733	CcSEcCtD
Codeine—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000541	0.0125	CbGpPWpGaD
Codeine—Visual impairment—Cisplatin—bone cancer	0.000532	0.00721	CcSEcCtD
Codeine—Eye disorder—Cisplatin—bone cancer	0.000516	0.00699	CcSEcCtD
Codeine—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000516	0.0119	CbGpPWpGaD
Codeine—Flushing—Cisplatin—bone cancer	0.000512	0.00694	CcSEcCtD
Codeine—Cardiac disorder—Cisplatin—bone cancer	0.000512	0.00694	CcSEcCtD
Codeine—Polyuria—Methotrexate—bone cancer	0.000499	0.00676	CcSEcCtD
Codeine—Immune system disorder—Cisplatin—bone cancer	0.000499	0.00675	CcSEcCtD
Codeine—Mediastinal disorder—Cisplatin—bone cancer	0.000498	0.00674	CcSEcCtD
Codeine—UGT2B4—Biological oxidations—CYP3A4—bone cancer	0.000482	0.0111	CbGpPWpGaD
Codeine—Erythema—Cisplatin—bone cancer	0.000481	0.00651	CcSEcCtD
Codeine—UGT2B4—Metapathway biotransformation—CYP3A4—bone cancer	0.000476	0.011	CbGpPWpGaD
Codeine—Visual disturbance—Methotrexate—bone cancer	0.000462	0.00626	CcSEcCtD
Codeine—Muscle spasms—Cisplatin—bone cancer	0.000462	0.00626	CcSEcCtD
Codeine—Tremor—Cisplatin—bone cancer	0.00045	0.0061	CcSEcCtD
Codeine—Ill-defined disorder—Cisplatin—bone cancer	0.000446	0.00604	CcSEcCtD
Codeine—Malaise—Cisplatin—bone cancer	0.000433	0.00587	CcSEcCtD
Codeine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000432	0.00994	CbGpPWpGaD
Codeine—Irritability—Methotrexate—bone cancer	0.000418	0.00566	CcSEcCtD
Codeine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000417	0.0096	CbGpPWpGaD
Codeine—Convulsion—Cisplatin—bone cancer	0.000416	0.00564	CcSEcCtD
Codeine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000415	0.00956	CbGpPWpGaD
Codeine—Mood swings—Methotrexate—bone cancer	0.000415	0.00562	CcSEcCtD
Codeine—UGT2B4—Biological oxidations—GSTP1—bone cancer	0.000412	0.0095	CbGpPWpGaD
Codeine—Diplopia—Epirubicin—bone cancer	0.00041	0.00555	CcSEcCtD
Codeine—Anxiety—Cisplatin—bone cancer	0.000408	0.00552	CcSEcCtD
Codeine—UGT2B4—Metapathway biotransformation—GSTP1—bone cancer	0.000407	0.00937	CbGpPWpGaD
Codeine—Discomfort—Cisplatin—bone cancer	0.000404	0.00548	CcSEcCtD
Codeine—Affect lability—Epirubicin—bone cancer	0.000403	0.00546	CcSEcCtD
Codeine—Breast disorder—Methotrexate—bone cancer	0.000396	0.00536	CcSEcCtD
Codeine—Cardiac arrest—Epirubicin—bone cancer	0.00039	0.00528	CcSEcCtD
Codeine—Mood swings—Epirubicin—bone cancer	0.000388	0.00526	CcSEcCtD
Codeine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000385	0.00886	CbGpPWpGaD
Codeine—Nervous system disorder—Cisplatin—bone cancer	0.000385	0.00521	CcSEcCtD
Codeine—Tachycardia—Cisplatin—bone cancer	0.000383	0.00518	CcSEcCtD
Codeine—Dehydration—Epirubicin—bone cancer	0.000381	0.00516	CcSEcCtD
Codeine—Diplopia—Doxorubicin—bone cancer	0.000379	0.00514	CcSEcCtD
Codeine—Hyperhidrosis—Cisplatin—bone cancer	0.000379	0.00514	CcSEcCtD
Codeine—Orthostatic hypotension—Epirubicin—bone cancer	0.000374	0.00507	CcSEcCtD
Codeine—Anorexia—Cisplatin—bone cancer	0.000374	0.00506	CcSEcCtD
Codeine—Affect lability—Doxorubicin—bone cancer	0.000373	0.00506	CcSEcCtD
Codeine—Pancreatitis—Methotrexate—bone cancer	0.000371	0.00503	CcSEcCtD
Codeine—Breast disorder—Epirubicin—bone cancer	0.00037	0.00502	CcSEcCtD
Codeine—Hypotension—Cisplatin—bone cancer	0.000367	0.00496	CcSEcCtD
Codeine—Nasopharyngitis—Epirubicin—bone cancer	0.000367	0.00496	CcSEcCtD
Codeine—Abdominal discomfort—Methotrexate—bone cancer	0.000363	0.00491	CcSEcCtD
Codeine—OPRD1—G alpha (i) signalling events—GRM4—bone cancer	0.000362	0.00834	CbGpPWpGaD
Codeine—OPRD1—G alpha (i) signalling events—RGS1—bone cancer	0.000362	0.00834	CbGpPWpGaD
Codeine—Cardiac arrest—Doxorubicin—bone cancer	0.000361	0.00488	CcSEcCtD
Codeine—Mood swings—Doxorubicin—bone cancer	0.000359	0.00487	CcSEcCtD
Codeine—Dehydration—Doxorubicin—bone cancer	0.000353	0.00478	CcSEcCtD
Codeine—Dyspnoea—Cisplatin—bone cancer	0.00035	0.00474	CcSEcCtD
Codeine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000349	0.00803	CbGpPWpGaD
Codeine—Pancreatitis—Epirubicin—bone cancer	0.000347	0.0047	CcSEcCtD
Codeine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000346	0.00469	CcSEcCtD
Codeine—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000344	0.00792	CbGpPWpGaD
Codeine—Breast disorder—Doxorubicin—bone cancer	0.000343	0.00464	CcSEcCtD
Codeine—Decreased appetite—Cisplatin—bone cancer	0.000341	0.00462	CcSEcCtD
Codeine—Nasopharyngitis—Doxorubicin—bone cancer	0.000339	0.00459	CcSEcCtD
Codeine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000339	0.00459	CcSEcCtD
Codeine—Drowsiness—Methotrexate—bone cancer	0.000338	0.00457	CcSEcCtD
Codeine—Depression—Methotrexate—bone cancer	0.000337	0.00456	CcSEcCtD
Codeine—Sweating—Methotrexate—bone cancer	0.000324	0.00438	CcSEcCtD
Codeine—Feeling abnormal—Cisplatin—bone cancer	0.000323	0.00438	CcSEcCtD
Codeine—Pancreatitis—Doxorubicin—bone cancer	0.000321	0.00435	CcSEcCtD
Codeine—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000321	0.0074	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—GRM4—bone cancer	0.000318	0.00732	CbGpPWpGaD
Codeine—OPRK1—G alpha (i) signalling events—RGS1—bone cancer	0.000318	0.00732	CbGpPWpGaD
Codeine—Drowsiness—Epirubicin—bone cancer	0.000316	0.00428	CcSEcCtD
Codeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000316	0.00727	CbGpPWpGaD
Codeine—Body temperature increased—Cisplatin—bone cancer	0.00031	0.0042	CcSEcCtD
Codeine—Sweating—Epirubicin—bone cancer	0.000303	0.0041	CcSEcCtD
Codeine—Urinary tract disorder—Methotrexate—bone cancer	0.000299	0.00405	CcSEcCtD
Codeine—Urethral disorder—Methotrexate—bone cancer	0.000297	0.00402	CcSEcCtD
Codeine—Drowsiness—Doxorubicin—bone cancer	0.000292	0.00396	CcSEcCtD
Codeine—Visual impairment—Methotrexate—bone cancer	0.000292	0.00395	CcSEcCtD
Codeine—UGT2B4—Metabolism—NDUFA12—bone cancer	0.000289	0.00666	CbGpPWpGaD
Codeine—Hypersensitivity—Cisplatin—bone cancer	0.000289	0.00391	CcSEcCtD
Codeine—Bradycardia—Epirubicin—bone cancer	0.000289	0.00391	CcSEcCtD
Codeine—Eye disorder—Methotrexate—bone cancer	0.000283	0.00383	CcSEcCtD
Codeine—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000283	0.00651	CbGpPWpGaD
Codeine—Asthenia—Cisplatin—bone cancer	0.000281	0.00381	CcSEcCtD
Codeine—Cardiac disorder—Methotrexate—bone cancer	0.000281	0.00381	CcSEcCtD
Codeine—Sweating—Doxorubicin—bone cancer	0.00028	0.00379	CcSEcCtD
Codeine—Urinary tract disorder—Epirubicin—bone cancer	0.00028	0.00379	CcSEcCtD
Codeine—Urethral disorder—Epirubicin—bone cancer	0.000278	0.00376	CcSEcCtD
Codeine—Immune system disorder—Methotrexate—bone cancer	0.000274	0.00371	CcSEcCtD
Codeine—Visual impairment—Epirubicin—bone cancer	0.000273	0.0037	CcSEcCtD
Codeine—Mediastinal disorder—Methotrexate—bone cancer	0.000273	0.0037	CcSEcCtD
Codeine—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	0.000268	0.00618	CbGpPWpGaD
Codeine—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	0.000268	0.00618	CbGpPWpGaD
Codeine—Bradycardia—Doxorubicin—bone cancer	0.000267	0.00362	CcSEcCtD
Codeine—Eye disorder—Epirubicin—bone cancer	0.000265	0.00359	CcSEcCtD
Codeine—Erythema—Methotrexate—bone cancer	0.000264	0.00357	CcSEcCtD
Codeine—Flushing—Epirubicin—bone cancer	0.000263	0.00356	CcSEcCtD
Codeine—Cardiac disorder—Epirubicin—bone cancer	0.000263	0.00356	CcSEcCtD
Codeine—Urinary tract disorder—Doxorubicin—bone cancer	0.000259	0.00351	CcSEcCtD
Codeine—Urethral disorder—Doxorubicin—bone cancer	0.000257	0.00348	CcSEcCtD
Codeine—Immune system disorder—Epirubicin—bone cancer	0.000256	0.00347	CcSEcCtD
Codeine—Mediastinal disorder—Epirubicin—bone cancer	0.000256	0.00346	CcSEcCtD
Codeine—Visual impairment—Doxorubicin—bone cancer	0.000253	0.00342	CcSEcCtD
Codeine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000252	0.0058	CbGpPWpGaD
Codeine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000252	0.00579	CbGpPWpGaD
Codeine—Vomiting—Cisplatin—bone cancer	0.000249	0.00338	CcSEcCtD
Codeine—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000249	0.00573	CbGpPWpGaD
Codeine—Rash—Cisplatin—bone cancer	0.000247	0.00335	CcSEcCtD
Codeine—Dermatitis—Cisplatin—bone cancer	0.000247	0.00335	CcSEcCtD
Codeine—Erythema—Epirubicin—bone cancer	0.000247	0.00334	CcSEcCtD
Codeine—Eye disorder—Doxorubicin—bone cancer	0.000245	0.00332	CcSEcCtD
Codeine—Ill-defined disorder—Methotrexate—bone cancer	0.000245	0.00331	CcSEcCtD
Codeine—Cardiac disorder—Doxorubicin—bone cancer	0.000244	0.0033	CcSEcCtD
Codeine—Flushing—Doxorubicin—bone cancer	0.000244	0.0033	CcSEcCtD
Codeine—Tension—Epirubicin—bone cancer	0.000242	0.00328	CcSEcCtD
Codeine—Nervousness—Epirubicin—bone cancer	0.00024	0.00325	CcSEcCtD
Codeine—UGT2B4—Metabolism—NT5C3A—bone cancer	0.00024	0.00552	CbGpPWpGaD
Codeine—Malaise—Methotrexate—bone cancer	0.000238	0.00322	CcSEcCtD
Codeine—Muscle spasms—Epirubicin—bone cancer	0.000237	0.00321	CcSEcCtD
Codeine—Immune system disorder—Doxorubicin—bone cancer	0.000237	0.00321	CcSEcCtD
Codeine—Vertigo—Methotrexate—bone cancer	0.000237	0.00321	CcSEcCtD
Codeine—Mediastinal disorder—Doxorubicin—bone cancer	0.000236	0.0032	CcSEcCtD
Codeine—Nausea—Cisplatin—bone cancer	0.000233	0.00316	CcSEcCtD
Codeine—Ill-defined disorder—Epirubicin—bone cancer	0.000229	0.0031	CcSEcCtD
Codeine—Convulsion—Methotrexate—bone cancer	0.000229	0.00309	CcSEcCtD
Codeine—Erythema—Doxorubicin—bone cancer	0.000228	0.00309	CcSEcCtD
Codeine—Agitation—Epirubicin—bone cancer	0.000227	0.00307	CcSEcCtD
Codeine—Tension—Doxorubicin—bone cancer	0.000224	0.00304	CcSEcCtD
Codeine—Malaise—Epirubicin—bone cancer	0.000223	0.00301	CcSEcCtD
Codeine—Discomfort—Methotrexate—bone cancer	0.000222	0.003	CcSEcCtD
Codeine—Nervousness—Doxorubicin—bone cancer	0.000222	0.003	CcSEcCtD
Codeine—Vertigo—Epirubicin—bone cancer	0.000222	0.003	CcSEcCtD
Codeine—Syncope—Epirubicin—bone cancer	0.000221	0.003	CcSEcCtD
Codeine—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.00022	0.00506	CbGpPWpGaD
Codeine—Muscle spasms—Doxorubicin—bone cancer	0.00022	0.00297	CcSEcCtD
Codeine—OPRD1—GPCR ligand binding—GRM4—bone cancer	0.000219	0.00505	CbGpPWpGaD
Codeine—Palpitations—Epirubicin—bone cancer	0.000218	0.00295	CcSEcCtD
Codeine—Confusional state—Methotrexate—bone cancer	0.000217	0.00294	CcSEcCtD
Codeine—Loss of consciousness—Epirubicin—bone cancer	0.000217	0.00294	CcSEcCtD
Codeine—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000217	0.00499	CbGpPWpGaD
Codeine—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000214	0.00493	CbGpPWpGaD
Codeine—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000214	0.00493	CbGpPWpGaD
Codeine—Convulsion—Epirubicin—bone cancer	0.000214	0.0029	CcSEcCtD
Codeine—Ill-defined disorder—Doxorubicin—bone cancer	0.000212	0.00287	CcSEcCtD
Codeine—Nervous system disorder—Methotrexate—bone cancer	0.000211	0.00286	CcSEcCtD
Codeine—Agitation—Doxorubicin—bone cancer	0.00021	0.00284	CcSEcCtD
Codeine—Anxiety—Epirubicin—bone cancer	0.000209	0.00284	CcSEcCtD
Codeine—Hyperhidrosis—Methotrexate—bone cancer	0.000208	0.00282	CcSEcCtD
Codeine—Discomfort—Epirubicin—bone cancer	0.000208	0.00281	CcSEcCtD
Codeine—Malaise—Doxorubicin—bone cancer	0.000206	0.00279	CcSEcCtD
Codeine—Dry mouth—Epirubicin—bone cancer	0.000206	0.00278	CcSEcCtD
Codeine—Vertigo—Doxorubicin—bone cancer	0.000205	0.00278	CcSEcCtD
Codeine—Anorexia—Methotrexate—bone cancer	0.000205	0.00278	CcSEcCtD
Codeine—Syncope—Doxorubicin—bone cancer	0.000205	0.00277	CcSEcCtD
Codeine—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000204	0.0047	CbGpPWpGaD
Codeine—Confusional state—Epirubicin—bone cancer	0.000203	0.00275	CcSEcCtD
Codeine—Palpitations—Doxorubicin—bone cancer	0.000202	0.00273	CcSEcCtD
Codeine—Hypotension—Methotrexate—bone cancer	0.000201	0.00272	CcSEcCtD
Codeine—Loss of consciousness—Doxorubicin—bone cancer	0.000201	0.00272	CcSEcCtD
Codeine—Shock—Epirubicin—bone cancer	0.000198	0.00268	CcSEcCtD
Codeine—Convulsion—Doxorubicin—bone cancer	0.000198	0.00268	CcSEcCtD
Codeine—Nervous system disorder—Epirubicin—bone cancer	0.000198	0.00268	CcSEcCtD
Codeine—Tachycardia—Epirubicin—bone cancer	0.000197	0.00266	CcSEcCtD
Codeine—Hyperhidrosis—Epirubicin—bone cancer	0.000195	0.00264	CcSEcCtD
Codeine—Insomnia—Methotrexate—bone cancer	0.000195	0.00264	CcSEcCtD
Codeine—Anxiety—Doxorubicin—bone cancer	0.000194	0.00262	CcSEcCtD
Codeine—OPRK1—GPCR ligand binding—GRM4—bone cancer	0.000192	0.00443	CbGpPWpGaD
Codeine—Discomfort—Doxorubicin—bone cancer	0.000192	0.0026	CcSEcCtD
Codeine—Anorexia—Epirubicin—bone cancer	0.000192	0.0026	CcSEcCtD
Codeine—Dyspnoea—Methotrexate—bone cancer	0.000192	0.0026	CcSEcCtD
Codeine—Somnolence—Methotrexate—bone cancer	0.000191	0.00259	CcSEcCtD
Codeine—Dry mouth—Doxorubicin—bone cancer	0.00019	0.00258	CcSEcCtD
Codeine—OPRD1—GPCR ligand binding—GRM1—bone cancer	0.00019	0.00438	CbGpPWpGaD
Codeine—Hypotension—Epirubicin—bone cancer	0.000188	0.00255	CcSEcCtD
Codeine—Confusional state—Doxorubicin—bone cancer	0.000188	0.00255	CcSEcCtD
Codeine—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000188	0.00433	CbGpPWpGaD
Codeine—Decreased appetite—Methotrexate—bone cancer	0.000187	0.00253	CcSEcCtD
Codeine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000186	0.00252	CcSEcCtD
Codeine—Fatigue—Methotrexate—bone cancer	0.000186	0.00251	CcSEcCtD
Codeine—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000185	0.00427	CbGpPWpGaD
Codeine—Shock—Doxorubicin—bone cancer	0.000183	0.00248	CcSEcCtD
Codeine—Nervous system disorder—Doxorubicin—bone cancer	0.000183	0.00248	CcSEcCtD
Codeine—Insomnia—Epirubicin—bone cancer	0.000182	0.00247	CcSEcCtD
Codeine—Tachycardia—Doxorubicin—bone cancer	0.000182	0.00246	CcSEcCtD
Codeine—Hyperhidrosis—Doxorubicin—bone cancer	0.00018	0.00244	CcSEcCtD
Codeine—Dyspnoea—Epirubicin—bone cancer	0.00018	0.00243	CcSEcCtD
Codeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000179	0.00413	CbGpPWpGaD
Codeine—Somnolence—Epirubicin—bone cancer	0.000179	0.00243	CcSEcCtD
Codeine—Anorexia—Doxorubicin—bone cancer	0.000178	0.00241	CcSEcCtD
Codeine—Feeling abnormal—Methotrexate—bone cancer	0.000177	0.0024	CcSEcCtD
Codeine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000177	0.00407	CbGpPWpGaD
Codeine—Gastrointestinal pain—Methotrexate—bone cancer	0.000176	0.00238	CcSEcCtD
Codeine—Decreased appetite—Epirubicin—bone cancer	0.000175	0.00237	CcSEcCtD
Codeine—Hypotension—Doxorubicin—bone cancer	0.000174	0.00236	CcSEcCtD
Codeine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000174	0.00236	CcSEcCtD
Codeine—Fatigue—Epirubicin—bone cancer	0.000174	0.00235	CcSEcCtD
Codeine—Constipation—Epirubicin—bone cancer	0.000172	0.00233	CcSEcCtD
Codeine—Urticaria—Methotrexate—bone cancer	0.000171	0.00232	CcSEcCtD
Codeine—Abdominal pain—Methotrexate—bone cancer	0.00017	0.0023	CcSEcCtD
Codeine—Body temperature increased—Methotrexate—bone cancer	0.00017	0.0023	CcSEcCtD
Codeine—Insomnia—Doxorubicin—bone cancer	0.000169	0.00228	CcSEcCtD
Codeine—OPRK1—GPCR ligand binding—GRM1—bone cancer	0.000167	0.00384	CbGpPWpGaD
Codeine—Dyspnoea—Doxorubicin—bone cancer	0.000166	0.00225	CcSEcCtD
Codeine—Feeling abnormal—Epirubicin—bone cancer	0.000166	0.00225	CcSEcCtD
Codeine—Somnolence—Doxorubicin—bone cancer	0.000166	0.00224	CcSEcCtD
Codeine—Gastrointestinal pain—Epirubicin—bone cancer	0.000165	0.00223	CcSEcCtD
Codeine—OPRM1—GPCR ligand binding—GRM4—bone cancer	0.000163	0.00374	CbGpPWpGaD
Codeine—Decreased appetite—Doxorubicin—bone cancer	0.000162	0.00219	CcSEcCtD
Codeine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000161	0.00218	CcSEcCtD
Codeine—Fatigue—Doxorubicin—bone cancer	0.000161	0.00218	CcSEcCtD
Codeine—Urticaria—Epirubicin—bone cancer	0.00016	0.00217	CcSEcCtD
Codeine—Constipation—Doxorubicin—bone cancer	0.000159	0.00216	CcSEcCtD
Codeine—Abdominal pain—Epirubicin—bone cancer	0.000159	0.00216	CcSEcCtD
Codeine—Body temperature increased—Epirubicin—bone cancer	0.000159	0.00216	CcSEcCtD
Codeine—Hypersensitivity—Methotrexate—bone cancer	0.000159	0.00215	CcSEcCtD
Codeine—Asthenia—Methotrexate—bone cancer	0.000154	0.00209	CcSEcCtD
Codeine—Feeling abnormal—Doxorubicin—bone cancer	0.000154	0.00208	CcSEcCtD
Codeine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000152	0.00206	CcSEcCtD
Codeine—Pruritus—Methotrexate—bone cancer	0.000152	0.00206	CcSEcCtD
Codeine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.00015	0.00346	CbGpPWpGaD
Codeine—Hypersensitivity—Epirubicin—bone cancer	0.000148	0.00201	CcSEcCtD
Codeine—Urticaria—Doxorubicin—bone cancer	0.000148	0.00201	CcSEcCtD
Codeine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000148	0.00341	CbGpPWpGaD
Codeine—Abdominal pain—Doxorubicin—bone cancer	0.000147	0.002	CcSEcCtD
Codeine—Body temperature increased—Doxorubicin—bone cancer	0.000147	0.002	CcSEcCtD
Codeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000145	0.00335	CbGpPWpGaD
Codeine—Asthenia—Epirubicin—bone cancer	0.000145	0.00196	CcSEcCtD
Codeine—Pruritus—Epirubicin—bone cancer	0.000143	0.00193	CcSEcCtD
Codeine—Dizziness—Methotrexate—bone cancer	0.000142	0.00193	CcSEcCtD
Codeine—OPRM1—GPCR ligand binding—GRM1—bone cancer	0.000141	0.00325	CbGpPWpGaD
Codeine—Hypersensitivity—Doxorubicin—bone cancer	0.000137	0.00186	CcSEcCtD
Codeine—Vomiting—Methotrexate—bone cancer	0.000137	0.00185	CcSEcCtD
Codeine—Rash—Methotrexate—bone cancer	0.000136	0.00184	CcSEcCtD
Codeine—Dermatitis—Methotrexate—bone cancer	0.000136	0.00184	CcSEcCtD
Codeine—OPRD1—GPCR ligand binding—SMO—bone cancer	0.000134	0.00309	CbGpPWpGaD
Codeine—Asthenia—Doxorubicin—bone cancer	0.000134	0.00181	CcSEcCtD
Codeine—Dizziness—Epirubicin—bone cancer	0.000133	0.0018	CcSEcCtD
Codeine—Pruritus—Doxorubicin—bone cancer	0.000132	0.00179	CcSEcCtD
Codeine—UGT2B7—Metabolism—NDUFA12—bone cancer	0.000132	0.00303	CbGpPWpGaD
Codeine—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000128	0.00296	CbGpPWpGaD
Codeine—Vomiting—Epirubicin—bone cancer	0.000128	0.00173	CcSEcCtD
Codeine—Nausea—Methotrexate—bone cancer	0.000128	0.00173	CcSEcCtD
Codeine—Rash—Epirubicin—bone cancer	0.000127	0.00172	CcSEcCtD
Codeine—Dermatitis—Epirubicin—bone cancer	0.000127	0.00172	CcSEcCtD
Codeine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000127	0.00292	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—RGS1—bone cancer	0.000124	0.00285	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—GRM4—bone cancer	0.000124	0.00285	CbGpPWpGaD
Codeine—Dizziness—Doxorubicin—bone cancer	0.000123	0.00167	CcSEcCtD
Codeine—Nausea—Epirubicin—bone cancer	0.00012	0.00162	CcSEcCtD
Codeine—Vomiting—Doxorubicin—bone cancer	0.000119	0.00161	CcSEcCtD
Codeine—Rash—Doxorubicin—bone cancer	0.000118	0.00159	CcSEcCtD
Codeine—OPRK1—GPCR ligand binding—SMO—bone cancer	0.000117	0.00271	CbGpPWpGaD
Codeine—Dermatitis—Doxorubicin—bone cancer	0.000117	0.00159	CcSEcCtD
Codeine—OPRM1—TCR Signaling Pathway—JUN—bone cancer	0.000117	0.0027	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—RGS1—bone cancer	0.000113	0.00259	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—GRM4—bone cancer	0.000113	0.00259	CbGpPWpGaD
Codeine—Nausea—Doxorubicin—bone cancer	0.000111	0.0015	CcSEcCtD
Codeine—UGT2B7—Metabolism—NT5C3A—bone cancer	0.000109	0.00251	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—RGS1—bone cancer	0.000109	0.0025	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—GRM4—bone cancer	0.000109	0.0025	CbGpPWpGaD
Codeine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000109	0.0025	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—GRM1—bone cancer	0.000107	0.00248	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000107	0.00247	CbGpPWpGaD
Codeine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000107	0.00246	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—ENO2—bone cancer	0.000105	0.00242	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—SMO—bone cancer	9.93e-05	0.00229	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—GRM4—bone cancer	9.87e-05	0.00227	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—RGS1—bone cancer	9.87e-05	0.00227	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—GRM1—bone cancer	9.76e-05	0.00225	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—DHFR—bone cancer	9.73e-05	0.00224	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—GRM1—bone cancer	9.42e-05	0.00217	CbGpPWpGaD
Codeine—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.28e-05	0.00214	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.25e-05	0.00213	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—GRM4—bone cancer	9.19e-05	0.00212	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—RGS1—bone cancer	9.19e-05	0.00212	CbGpPWpGaD
Codeine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.15e-05	0.00211	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—GNA11—bone cancer	9.1e-05	0.0021	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NDUFA12—bone cancer	9e-05	0.00207	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—GRM1—bone cancer	8.56e-05	0.00197	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NDUFA12—bone cancer	8.37e-05	0.00193	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—GRM4—bone cancer	8.34e-05	0.00192	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—RGS1—bone cancer	8.34e-05	0.00192	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—CYP3A4—bone cancer	8.25e-05	0.0019	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—GRM1—bone cancer	7.96e-05	0.00183	CbGpPWpGaD
Codeine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.72e-05	0.00178	CbGpPWpGaD
Codeine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.61e-05	0.00175	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NT5C3A—bone cancer	7.46e-05	0.00172	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—GRM1—bone cancer	7.23e-05	0.00167	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—GSTP1—bone cancer	7.05e-05	0.00162	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NT5C3A—bone cancer	6.94e-05	0.0016	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—GNA11—bone cancer	6.92e-05	0.00159	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—SMO—bone cancer	6.88e-05	0.00158	CbGpPWpGaD
Codeine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	6.79e-05	0.00156	CbGpPWpGaD
Codeine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.66e-05	0.00153	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—RGS1—bone cancer	6.65e-05	0.00153	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—GRM4—bone cancer	6.65e-05	0.00153	CbGpPWpGaD
Codeine—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.6e-05	0.00152	CbGpPWpGaD
Codeine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.51e-05	0.0015	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NDUFA12—bone cancer	6.5e-05	0.0015	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—GNA11—bone cancer	6.29e-05	0.00145	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—IL3—bone cancer	6.28e-05	0.00145	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—GNA11—bone cancer	6.07e-05	0.0014	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—SMO—bone cancer	6.03e-05	0.00139	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—GRM4—bone cancer	5.83e-05	0.00134	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—RGS1—bone cancer	5.83e-05	0.00134	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—GRM1—bone cancer	5.76e-05	0.00133	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—IL3—bone cancer	5.7e-05	0.00131	CbGpPWpGaD
Codeine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	5.69e-05	0.00131	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—GNA11—bone cancer	5.51e-05	0.00127	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—IL3—bone cancer	5.51e-05	0.00127	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NT5C3A—bone cancer	5.39e-05	0.00124	CbGpPWpGaD
Codeine—SLC22A1—Neuronal System—BRAF—bone cancer	5.2e-05	0.0012	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—GNA11—bone cancer	5.13e-05	0.00118	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—SMO—bone cancer	5.1e-05	0.00117	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—GRM1—bone cancer	5.06e-05	0.00116	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL3—bone cancer	5e-05	0.00115	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—GRM4—bone cancer	4.93e-05	0.00113	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—RGS1—bone cancer	4.93e-05	0.00113	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—ENO2—bone cancer	4.78e-05	0.0011	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—GNA11—bone cancer	4.66e-05	0.00107	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—IL3—bone cancer	4.65e-05	0.00107	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NDUFA12—bone cancer	4.63e-05	0.00107	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—DHFR—bone cancer	4.43e-05	0.00102	CbGpPWpGaD
Codeine—SLC22A1—Neuronal System—MDM2—bone cancer	4.36e-05	0.001	CbGpPWpGaD
Codeine—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.31e-05	0.000994	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—GRM1—bone cancer	4.27e-05	0.000984	CbGpPWpGaD
Codeine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.26e-05	0.00098	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL3—bone cancer	4.23e-05	0.000973	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GNA11—bone cancer	4.14e-05	0.000954	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—SMO—bone cancer	4.06e-05	0.000935	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.83e-05	0.000883	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—CYP3A4—bone cancer	3.76e-05	0.000865	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—GNA11—bone cancer	3.71e-05	0.000856	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PTGS2—bone cancer	3.65e-05	0.000842	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—SMO—bone cancer	3.56e-05	0.00082	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ATF1—bone cancer	3.45e-05	0.000795	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL3—bone cancer	3.37e-05	0.000776	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—ENO2—bone cancer	3.27e-05	0.000752	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—GNA11—bone cancer	3.26e-05	0.00075	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GSTP1—bone cancer	3.21e-05	0.00074	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—ENO2—bone cancer	3.04e-05	0.0007	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—DHFR—bone cancer	3.03e-05	0.000698	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ATF1—bone cancer	3.03e-05	0.000697	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.02e-05	0.000696	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—SMO—bone cancer	3.01e-05	0.000693	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL3—bone cancer	2.95e-05	0.00068	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TGFBR2—bone cancer	2.88e-05	0.000663	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GNA11—bone cancer	2.83e-05	0.000652	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—DHFR—bone cancer	2.82e-05	0.000649	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—GNA11—bone cancer	2.75e-05	0.000634	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IGF1R—bone cancer	2.71e-05	0.000624	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GNA11—bone cancer	2.64e-05	0.000607	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—CYP3A4—bone cancer	2.57e-05	0.000591	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ATF1—bone cancer	2.56e-05	0.000589	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TGFBR2—bone cancer	2.53e-05	0.000582	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.51e-05	0.000577	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL3—bone cancer	2.5e-05	0.000575	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CYP3A4—bone cancer	2.39e-05	0.00055	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IGF1R—bone cancer	2.38e-05	0.000547	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—ENO2—bone cancer	2.36e-05	0.000544	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTP1—bone cancer	2.2e-05	0.000506	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—DHFR—bone cancer	2.19e-05	0.000504	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TGFBR2—bone cancer	2.13e-05	0.000492	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GNA11—bone cancer	2.05e-05	0.000471	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTP1—bone cancer	2.04e-05	0.000471	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IGF1R—bone cancer	2.01e-05	0.000463	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—KIT—bone cancer	1.97e-05	0.000453	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.86e-05	0.000427	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—BRAF—bone cancer	1.85e-05	0.000425	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—EGFR—bone cancer	1.79e-05	0.000412	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000397	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ENO2—bone cancer	1.68e-05	0.000387	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PTGS2—bone cancer	1.66e-05	0.000383	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.000373	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTP1—bone cancer	1.59e-05	0.000366	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000362	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—DHFR—bone cancer	1.56e-05	0.000359	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MDM2—bone cancer	1.55e-05	0.000357	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—KIT—bone cancer	1.46e-05	0.000335	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GNA11—bone cancer	1.46e-05	0.000335	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—BRAF—bone cancer	1.37e-05	0.000315	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MDM2—bone cancer	1.36e-05	0.000313	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—JUN—bone cancer	1.35e-05	0.00031	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—EGFR—bone cancer	1.33e-05	0.000306	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.32e-05	0.000304	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MMP9—bone cancer	1.31e-05	0.000301	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—JUN—bone cancer	1.18e-05	0.000272	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000264	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MDM2—bone cancer	1.15e-05	0.000264	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PTGS2—bone cancer	1.14e-05	0.000262	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTP1—bone cancer	1.13e-05	0.00026	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ENO2—bone cancer	1.1e-05	0.000253	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PTGS2—bone cancer	1.06e-05	0.000244	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—EGFR—bone cancer	1.06e-05	0.000244	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—DHFR—bone cancer	1.02e-05	0.000234	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—JUN—bone cancer	9.97e-06	0.00023	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MMP9—bone cancer	9.7e-06	0.000223	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GNA11—bone cancer	9.52e-06	0.000219	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—EGFR—bone cancer	9.28e-06	0.000214	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TP53—bone cancer	8.88e-06	0.000205	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PTGS2—bone cancer	8.22e-06	0.000189	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—EGFR—bone cancer	7.84e-06	0.000181	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TP53—bone cancer	7.79e-06	0.000179	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTP1—bone cancer	7.38e-06	0.00017	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TP53—bone cancer	6.58e-06	0.000152	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PTGS2—bone cancer	5.85e-06	0.000135	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PTGS2—bone cancer	3.82e-06	8.8e-05	CbGpPWpGaD
